Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation.
Saved in:
| Title: | Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation. |
|---|---|
| Authors: | Gong W; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Chen X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Shi T; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Shao X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., An X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Qin J; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China., Chen X; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China., Jiang Q; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.; Laboratory for Bone and Joint Disease, Model Animal Research Center (MARC), Medical School, Nanjing University, Nanjing, China., Guo B; Department of Sports Medicine and Adult Reconstructive Surgery, The Affiliated Hospital of Nanjing University Medical School and State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China.; Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2021 Oct 01; Vol. 12, pp. 727808. Date of Electronic Publication: 2021 Oct 01 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2021.727808 |
